| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Cathepsin K |
|---|
| Ligand | BDBM50328895 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_673957 (CHEMBL1275134) |
|---|
| IC50 | 12±n/a nM |
|---|
| Citation |  Rankovic, Z; Cai, J; Kerr, J; Fradera, X; Robinson, J; Mistry, A; Finlay, W; McGarry, G; Andrews, F; Caulfield, W; Cumming, I; Dempster, M; Waller, J; Arbuckle, W; Anderson, M; Martin, I; Mitchell, A; Long, C; Baugh, M; Westwood, P; Kinghorn, E; Jones, P; Uitdehaag, JC; van Zeeland, M; Potin, D; Saniere, L; Fouquet, A; Chevallier, F; Deronzier, H; Dorleans, C; Nicolai, E Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: improving selectivity over hERG. Bioorg Med Chem Lett20:6237-41 (2010) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Cathepsin K |
|---|
| Name: | Cathepsin K |
|---|
| Synonyms: | CATK_HUMAN | CTSK | CTSO | CTSO2 | Cathepsin O | Cathepsin O2 | Cathepsin X |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 36975.68 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P43235 |
|---|
| Residue: | 329 |
|---|
| Sequence: | MWGLKVLLLPVVSFALYPEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIH
NLEASLGVHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGRAPDSVD
YRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGG
YMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVA
RVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGE
NWGNKGYILMARNKNNACGIANLASFPKM
|
|
|
|---|
| BDBM50328895 |
|---|
| n/a |
|---|
| Name | BDBM50328895 |
|---|
| Synonyms: | 1-(3-(2-cyano-6-(3-(trifluoromethyl)phenyl)pyrimidin-4-yl)propylamino)cyclopropanecarboxamide | CHEMBL1270366 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C19H18F3N5O |
|---|
| Mol. Mass. | 389.3743 |
|---|
| SMILES | NC(=O)C1(CC1)NCCCc1cc(nc(n1)C#N)-c1cccc(c1)C(F)(F)F |
|---|
| Structure | 
|
|---|
Search and Browse
